Search - tctmd.com

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar

January 31, 2013

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Industry News

Loma Vista Medical receives FDA clearance for its TRUE Dilatation™ Balloon Valvuloplasty Catheter

October 17, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

August 07, 2012

News Daily News

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Jason Kahn

July 31, 2012

Presentation TVT 2012

Case Management Challenges: When Is BAV Appropriate?

Presenter: Augusto Pichard

June 04, 2012

News Industry News

Loma Vista Medical receives CE mark for its TRUE Dilatation™ Balloon Valvuloplasty Catheter

May 10, 2012

Presentation TCT 2012

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Vicken Aharonian, Prakash Mansukhani, Gregg W. Stone, Naing Moore, Ric Hyett, Richard Contreras, Somjot S. Brar

January 03, 2012

Presentation TCT 2012

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee

January 03, 2012

News Industry News

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

November 09, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Industry News

St. Jude Medical Announces FDA Approval of Trifecta Valve

April 20, 2011

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Caitlin E. Cox

March 18, 2011

News Daily News

GPIs in Elective PCI: Older Drugs Still Have a Role

February 27, 2011

Advertisement

Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections

Meta-analysis: Manual, Not Mechanical, Thrombectomy Holds Advantages Over PCI

Meta Análisis: Trombectomía Manual, No Mecánica ofrece Ventajas durante una PCI

Intervalve Inc. Receives 510(k) Clearance in the United States for the V8 Aortic Valvuloplasty Balloon Catheter

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

Loma Vista Medical receives FDA clearance for its TRUE Dilatation™ Balloon Valvuloplasty Catheter

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Case Management Challenges: When Is BAV Appropriate?

Loma Vista Medical receives CE mark for its TRUE Dilatation™ Balloon Valvuloplasty Catheter

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

St. Jude Medical Announces FDA Approval of Trifecta Valve

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

GPIs in Elective PCI: Older Drugs Still Have a Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content